Keywords
IL-6
IL-10
Traumatic brain injury
Abstract
Introduction: Traumatic brain injury (TBI) represents a major global health burden, because it is the foremost causes of death, particularly in young adults. Elevated IL-6 and IL-10 serum levels in severe TBI have been identified as an early indicator of unfavorable clinical outcomes. Pegagan (Centella asiatica (L.)) has antioxidant, neuroprotective, neurogenerative, anti-inflammatory properties. Our goal of this study was to find out what happened to IL-6 and IL-10 levels in blood of the TBI rat model when they were given pegagan extract (Centella asiatica (L.)).
Subject and Method: experimental research design. For 3 days, there were 4 groups of male Wistar strain rats (Rattus norvegicus) subjects, consisting of three treatment groups (pegagan extract doses of 300 mg/kgBW, 500 mg/kgBW, and 1000 mg/kgBW) and one control group. On the 4th day, blood was taken, and we continued to examine IL-6 and IL-10 serum levels by ELISA.
Result: A dose-dependent and significant increase of IL-6 and IL-10 serum levels was observed in the treatment groups compared with control group.
Conclusion: In TBI rat model, administration of pegagan (Centella asiatica (L.)) extract increases IL-6 and IL-10 levels.
References
Roozenbeek B, Maas AIR, Menon DK. Changing patterns in the epidemiology of traumatic brain injury. Nat. Rev. Neurol. 2013;9:231–236. Doi: 10.1038/nrneurol.2013.22
Prasetyo E. The primary, secondary, and tertiary brain injury. Crit Care Shock, 2020, 23(1): 4-13.
Bao W, Lin Y, Chen Z. The Peripheral Immune System and Traumatic Brain Injury: Insight into the role of T-helper cells. Int. J. Med. Sci. 2021;18(16):3644–51. Doi: 10.7150/ijms.46834.
DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem. 2016;139 Suppl 2(Suppl 2):136-153. Doi: 10.1111/jnc.13607.
Ferreira LC, Regner A, Miotto KD, Moura Sd, Ikuta N, Vargas AE, Chies JA, Simon D. Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury. Brain Inj. 2014;28(10):1311-6. doi: 10.3109/02699052.2014.916818.
Natsir R, Prasetyo E, Oley MC, Langi FLFG. Hubungan kadar interleukin 6 dan interleukin 10 Serum pada pasien cedera otak berat akibat trauma. J Biomedik. 2021; 13(28):1–8.
Prakash V, Jaiswal N, Srivastava M. A review on medicinal properties of Centella asiatica. Asian J Pharm Clin Res. 2017; 10(10):69–74. doi:10.22159/ajpcr.2017.v10i10.20760
Chandrika UG and AAS Prasad Kumara P. Gotu Kola (Centella Asiatica): Nutritional Properties and Plausible Health Benefits, Adv Food Nutr Res. 2015;76:125–57. Doi: 10.1016/bs.afnr.2015.08.001.
Bandopadhyay S, Mandal S, Ghorai M, Jha NK, Kumar M, Radha GA, et al. “Therapeutic properties and pharmacological activities of asiaticoside and madecassoside: A reviewâ€. J Cell Mol Med. 2023;27(5: 593–608. Doi: 10.1111/jcmm.17635.
Nafiisah N, Faniyah F, Pratama YM. Anti-inflammatory effect of centella asiatica (L.) extract by decreasing TNF-α serum levels in rat model of traumatic brain injury. Majalah Kedokteran Bandung. 2021;53 (2):63-66.
Efendi, Y. Ekspresi interleukin 6 dan gambaran histopatologi cerebrum pada tikus (Rattus norvegicus) model traumatic brain injuryâ€, Universitas Brawijaya. 2017
Hao C, Wu B, Hou Z, Xie Q, Liao T, Wang T, Ma D. Asiatic acid inhibits LPS- induced inflammatory response in human gingival fibroblasts. Int Immunopharmacol. 2017;50:313-18. Doi: 10.1016/j.intimp.2017.07.005.
Rose-John S, Winthrop K, Calabrese L. The role of IL-6 in host defence against infections: immunobiology and clinical implications. Nat Rev Rheumatol. 2017;13(7):399-409. doi: 10.1038/nrrheum.2017.83.
Besung INK, Astawa NM, Suatha IK. Centella asiatica extract increased on the level of interleukin 6 (IL-6) in mice J Biol Med Biochem. 2012:1-7.
Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012; 8(9):1254–266. Doi: 10.7150/ijbs.4679.
Diniz LRL, Calado LL, Duarte ABS, de Sousa DP. Centella asiatica and its metabolite asiatic acid: wound healing effects and therapeutic potential. Metabolites. 2023; 13 (2): 276. Doi: 10.3390/metabo13020276.
Hirayama D, Iida T, Nakase H. The phagocytic function of macrophage- enforcing innate immunity and tissue homeostasis. Int J Mol Sci. 2017;29;19(1):92. Doi: 10.3390/ijms19010092.
Lobo-Silva D, Carriche GM, Castro AG, Roque S, Saraiva M. Balancing the immune response in the brain: IL-10 and its regulation. J Neuroinflammation. 2016;13(1):297. Doi: 10.1186/s12974-016-0763-8.
Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012;32(1):23-63. Doi: 10.1615/critrevimmunol.v32.i1.30
Kim J, Lee S, Kang S, Kim SH, Kim JC, Yang M, Moon C. Brain-derived neurotropic factor and GABAergic transmission in neurodegeneration and neuroregeneration. Neural Regen Res. 2017;12(10):1733-741. doi: 10.4103/1673-5374.217353.